| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Janus Kinase 2 | 7 | 2010 | 679 | 1.090 |
Why?
|
| Polycythemia Vera | 5 | 2008 | 238 | 0.870 |
Why?
|
| Erythroid Precursor Cells | 4 | 2010 | 61 | 0.640 |
Why?
|
| Chloroplasts | 4 | 2000 | 14 | 0.600 |
Why?
|
| DNA-Directed DNA Polymerase | 4 | 2002 | 182 | 0.560 |
Why?
|
| Translocation, Genetic | 3 | 2017 | 1245 | 0.520 |
Why?
|
| Immunophenotyping | 3 | 2018 | 1681 | 0.510 |
Why?
|
| Interleukin-2 Receptor alpha Subunit | 1 | 2014 | 105 | 0.480 |
Why?
|
| Myeloid Cells | 1 | 2014 | 269 | 0.440 |
Why?
|
| Cytogenetic Analysis | 1 | 2014 | 568 | 0.440 |
Why?
|
| Cell Lineage | 1 | 2014 | 668 | 0.400 |
Why?
|
| Philadelphia Chromosome | 1 | 2014 | 793 | 0.370 |
Why?
|
| Adipose Tissue, Brown | 4 | 1991 | 112 | 0.370 |
Why?
|
| Plant Proteins | 3 | 2000 | 133 | 0.350 |
Why?
|
| Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2014 | 482 | 0.350 |
Why?
|
| Lymphocytes | 1 | 2014 | 1234 | 0.350 |
Why?
|
| Fusion Proteins, bcr-abl | 1 | 2014 | 1094 | 0.330 |
Why?
|
| Point Mutation | 2 | 2008 | 769 | 0.330 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 | 2014 | 2796 | 0.320 |
Why?
|
| Triterpenes | 2 | 2005 | 61 | 0.310 |
Why?
|
| Alleles | 4 | 2010 | 2437 | 0.300 |
Why?
|
| Saponins | 4 | 2008 | 34 | 0.290 |
Why?
|
| Down Syndrome | 1 | 2008 | 226 | 0.270 |
Why?
|
| Protein Kinase Inhibitors | 4 | 2010 | 4757 | 0.260 |
Why?
|
| Sezary Syndrome | 2 | 2008 | 159 | 0.250 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2005 | 161 | 0.240 |
Why?
|
| Flow Cytometry | 4 | 2018 | 3033 | 0.240 |
Why?
|
| Leukemia | 2 | 2020 | 1635 | 0.240 |
Why?
|
| Apoptosis | 9 | 2019 | 7591 | 0.240 |
Why?
|
| Signal Transduction | 5 | 2019 | 11965 | 0.230 |
Why?
|
| Leukemia, Megakaryoblastic, Acute | 1 | 2022 | 47 | 0.210 |
Why?
|
| T-Lymphocytes | 4 | 2021 | 3869 | 0.210 |
Why?
|
| NADH, NADPH Oxidoreductases | 1 | 2001 | 21 | 0.200 |
Why?
|
| Telomere Shortening | 1 | 2021 | 56 | 0.200 |
Why?
|
| Neoplasms, Second Primary | 2 | 2021 | 1350 | 0.200 |
Why?
|
| Pyrimidines | 3 | 2008 | 3518 | 0.190 |
Why?
|
| Atovaquone | 1 | 2019 | 8 | 0.180 |
Why?
|
| Cell Proliferation | 5 | 2010 | 7226 | 0.180 |
Why?
|
| Enzyme Activation | 5 | 2008 | 1764 | 0.180 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferases | 1 | 2022 | 310 | 0.170 |
Why?
|
| Mitochondria | 3 | 1991 | 1282 | 0.170 |
Why?
|
| Precursor Cells, B-Lymphoid | 1 | 2019 | 35 | 0.170 |
Why?
|
| Tertiary Healthcare | 1 | 2019 | 44 | 0.170 |
Why?
|
| Glycoproteins | 2 | 2000 | 747 | 0.170 |
Why?
|
| Leukemia, Myelomonocytic, Juvenile | 1 | 2019 | 33 | 0.170 |
Why?
|
| Myeloid-Lymphoid Leukemia Protein | 1 | 2020 | 197 | 0.160 |
Why?
|
| Oxidative Phosphorylation | 1 | 2019 | 253 | 0.160 |
Why?
|
| Leukemia, Myeloid, Acute | 4 | 2019 | 6915 | 0.160 |
Why?
|
| Piperazines | 1 | 2007 | 2101 | 0.160 |
Why?
|
| Cytoskeletal Proteins | 1 | 2000 | 492 | 0.150 |
Why?
|
| Mutation, Missense | 3 | 2007 | 1152 | 0.150 |
Why?
|
| Viruses | 1 | 2018 | 159 | 0.150 |
Why?
|
| Chromosomes, Human, Pair 6 | 1 | 2017 | 179 | 0.140 |
Why?
|
| Base Sequence | 5 | 2007 | 4917 | 0.140 |
Why?
|
| Proteins | 1 | 2005 | 1963 | 0.140 |
Why?
|
| Lymphoproliferative Disorders | 1 | 2019 | 366 | 0.140 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2017 | 327 | 0.140 |
Why?
|
| Lymphoma | 1 | 2005 | 1467 | 0.140 |
Why?
|
| Immunity, Cellular | 1 | 2018 | 419 | 0.140 |
Why?
|
| Lymphoma, T-Cell | 1 | 2019 | 361 | 0.140 |
Why?
|
| Adipose Tissue | 1 | 2001 | 769 | 0.140 |
Why?
|
| Interleukin-3 Receptor alpha Subunit | 1 | 2016 | 106 | 0.130 |
Why?
|
| Biomarkers, Tumor | 1 | 2014 | 10331 | 0.130 |
Why?
|
| Hot Temperature | 3 | 1990 | 281 | 0.130 |
Why?
|
| NADPH Dehydrogenase | 2 | 2005 | 10 | 0.130 |
Why?
|
| Child, Preschool | 7 | 2019 | 16273 | 0.130 |
Why?
|
| Herpesvirus 4, Human | 1 | 2019 | 966 | 0.120 |
Why?
|
| Cancer Survivors | 1 | 2021 | 650 | 0.120 |
Why?
|
| Epstein-Barr Virus Infections | 1 | 2019 | 489 | 0.120 |
Why?
|
| Graft Survival | 1 | 2018 | 1062 | 0.120 |
Why?
|
| Virus Diseases | 1 | 2018 | 398 | 0.120 |
Why?
|
| Intellectual Disability | 1 | 2022 | 1032 | 0.120 |
Why?
|
| Child | 9 | 2021 | 29154 | 0.120 |
Why?
|
| DNA, Complementary | 3 | 2000 | 869 | 0.120 |
Why?
|
| Bacterial Proteins | 1 | 2000 | 1029 | 0.120 |
Why?
|
| Antigens, Surface | 1 | 2014 | 295 | 0.120 |
Why?
|
| Graft Rejection | 1 | 2018 | 834 | 0.120 |
Why?
|
| Escherichia coli | 1 | 2000 | 1203 | 0.120 |
Why?
|
| Cold Temperature | 2 | 1990 | 121 | 0.110 |
Why?
|
| Azacitidine | 1 | 2019 | 1149 | 0.110 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 2019 | 1299 | 0.110 |
Why?
|
| Infant | 6 | 2019 | 13310 | 0.110 |
Why?
|
| Oxygen Consumption | 2 | 1991 | 401 | 0.110 |
Why?
|
| Age Factors | 2 | 2014 | 5377 | 0.110 |
Why?
|
| DNA Primers | 2 | 2007 | 1399 | 0.100 |
Why?
|
| Humans | 27 | 2022 | 261506 | 0.100 |
Why?
|
| Erythropoietin | 3 | 2008 | 205 | 0.100 |
Why?
|
| Neuroblastoma | 1 | 2017 | 686 | 0.100 |
Why?
|
| Transduction, Genetic | 2 | 2016 | 475 | 0.100 |
Why?
|
| Rats, Inbred Strains | 5 | 1992 | 410 | 0.100 |
Why?
|
| Cytochrome c Group | 1 | 1991 | 71 | 0.100 |
Why?
|
| Oxidation-Reduction | 4 | 2005 | 717 | 0.100 |
Why?
|
| Cytochromes | 1 | 1990 | 10 | 0.100 |
Why?
|
| Thyroid Neoplasms | 1 | 2021 | 1866 | 0.090 |
Why?
|
| Cells, Cultured | 3 | 2008 | 5637 | 0.090 |
Why?
|
| Triiodothyronine | 1 | 1990 | 77 | 0.090 |
Why?
|
| Janus Kinase 3 | 1 | 2010 | 46 | 0.090 |
Why?
|
| Acclimatization | 1 | 1990 | 42 | 0.090 |
Why?
|
| Mutation | 5 | 2010 | 15179 | 0.090 |
Why?
|
| Molecular Sequence Data | 4 | 2002 | 6089 | 0.090 |
Why?
|
| Spiro Compounds | 1 | 2010 | 58 | 0.090 |
Why?
|
| Thyroxine | 1 | 1990 | 116 | 0.090 |
Why?
|
| Langerhans Cells | 1 | 2010 | 50 | 0.090 |
Why?
|
| Up-Regulation | 2 | 2014 | 2450 | 0.090 |
Why?
|
| Glycosylation | 2 | 2000 | 213 | 0.090 |
Why?
|
| Liver Transplantation | 1 | 2018 | 1112 | 0.090 |
Why?
|
| Oxidoreductases | 1 | 1990 | 171 | 0.090 |
Why?
|
| Epidermis | 1 | 2010 | 188 | 0.090 |
Why?
|
| X-Linked Inhibitor of Apoptosis Protein | 2 | 2010 | 119 | 0.090 |
Why?
|
| Cloning, Molecular | 3 | 2000 | 1213 | 0.090 |
Why?
|
| Diploidy | 1 | 2008 | 114 | 0.080 |
Why?
|
| Microtubule-Associated Proteins | 2 | 2008 | 534 | 0.080 |
Why?
|
| Hemoglobins, Abnormal | 1 | 2007 | 19 | 0.080 |
Why?
|
| Male | 16 | 2021 | 123000 | 0.080 |
Why?
|
| Apoptosis Regulatory Proteins | 2 | 2007 | 621 | 0.080 |
Why?
|
| Female | 14 | 2021 | 141928 | 0.080 |
Why?
|
| NAD(P)H Dehydrogenase (Quinone) | 2 | 2005 | 60 | 0.080 |
Why?
|
| Ubiquitin-Activating Enzymes | 1 | 2007 | 50 | 0.080 |
Why?
|
| Cell Line, Tumor | 6 | 2019 | 14551 | 0.070 |
Why?
|
| Cytochrome-B(5) Reductase | 1 | 2006 | 6 | 0.070 |
Why?
|
| Methemoglobinemia | 1 | 2006 | 18 | 0.070 |
Why?
|
| Histiocytosis, Langerhans-Cell | 1 | 2010 | 261 | 0.070 |
Why?
|
| Granulocytes | 1 | 2007 | 224 | 0.070 |
Why?
|
| Culture Media | 1 | 2007 | 319 | 0.070 |
Why?
|
| Multienzyme Complexes | 1 | 2007 | 213 | 0.070 |
Why?
|
| STAT5 Transcription Factor | 1 | 2007 | 214 | 0.070 |
Why?
|
| Phenotype | 1 | 2017 | 6295 | 0.070 |
Why?
|
| Purines | 1 | 2007 | 273 | 0.070 |
Why?
|
| Phosphorylation | 3 | 2010 | 4804 | 0.070 |
Why?
|
| Terpenes | 1 | 2005 | 34 | 0.070 |
Why?
|
| Adolescent | 5 | 2021 | 31252 | 0.070 |
Why?
|
| Predictive Value of Tests | 1 | 2014 | 4892 | 0.070 |
Why?
|
| Cytokinesis | 1 | 2005 | 57 | 0.070 |
Why?
|
| Amino Acid Sequence | 3 | 2000 | 4233 | 0.070 |
Why?
|
| Benzo(a)pyrene | 1 | 2005 | 35 | 0.070 |
Why?
|
| NAD | 2 | 2005 | 89 | 0.060 |
Why?
|
| Animals | 14 | 2022 | 59536 | 0.060 |
Why?
|
| Schizosaccharomyces | 1 | 2005 | 116 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2007 | 479 | 0.060 |
Why?
|
| Lymphoma, T-Cell, Cutaneous | 1 | 2008 | 294 | 0.060 |
Why?
|
| Ubiquitins | 1 | 2005 | 86 | 0.060 |
Why?
|
| STAT3 Transcription Factor | 2 | 2008 | 1121 | 0.060 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2018 | 6207 | 0.060 |
Why?
|
| Rats | 6 | 2004 | 6086 | 0.060 |
Why?
|
| Blotting, Western | 3 | 2008 | 3536 | 0.060 |
Why?
|
| Pyrroles | 1 | 2008 | 576 | 0.060 |
Why?
|
| Insulin | 1 | 1990 | 1454 | 0.060 |
Why?
|
| Polymerase Chain Reaction | 2 | 2007 | 3203 | 0.060 |
Why?
|
| Exons | 1 | 2007 | 1328 | 0.060 |
Why?
|
| Liver | 3 | 2019 | 2961 | 0.060 |
Why?
|
| Prognosis | 3 | 2019 | 21713 | 0.060 |
Why?
|
| Mice | 8 | 2022 | 34495 | 0.060 |
Why?
|
| Bone Marrow | 3 | 2019 | 2358 | 0.060 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 2 | 2002 | 568 | 0.060 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2008 | 852 | 0.060 |
Why?
|
| Ubiquitin | 1 | 2005 | 344 | 0.060 |
Why?
|
| Sex Factors | 1 | 2008 | 2139 | 0.060 |
Why?
|
| Imatinib Mesylate | 1 | 2007 | 1665 | 0.060 |
Why?
|
| Mice, Knockout | 3 | 2019 | 5710 | 0.050 |
Why?
|
| Immunotherapy | 1 | 2016 | 3341 | 0.050 |
Why?
|
| CD3 Complex | 2 | 2016 | 314 | 0.050 |
Why?
|
| Exodeoxyribonuclease V | 1 | 2002 | 28 | 0.050 |
Why?
|
| DNA, Plant | 1 | 2002 | 17 | 0.050 |
Why?
|
| Nucleic Acid Synthesis Inhibitors | 1 | 2002 | 43 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2008 | 1493 | 0.050 |
Why?
|
| Benzamides | 1 | 2007 | 1832 | 0.050 |
Why?
|
| Exodeoxyribonucleases | 1 | 2002 | 104 | 0.050 |
Why?
|
| FMN Reductase | 1 | 2001 | 9 | 0.050 |
Why?
|
| Cell Survival | 2 | 2019 | 3045 | 0.050 |
Why?
|
| Central Nervous System | 1 | 2004 | 436 | 0.050 |
Why?
|
| NADP | 1 | 2001 | 96 | 0.050 |
Why?
|
| Autophagy | 1 | 2007 | 927 | 0.050 |
Why?
|
| Sequence Analysis, DNA | 1 | 2008 | 2483 | 0.050 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 1999 | 997 | 0.050 |
Why?
|
| Electron Transport | 2 | 1990 | 79 | 0.050 |
Why?
|
| Tumor Cells, Cultured | 2 | 2005 | 5395 | 0.050 |
Why?
|
| Guanosine Triphosphate | 1 | 2000 | 90 | 0.050 |
Why?
|
| Genetic Complementation Test | 1 | 2000 | 125 | 0.050 |
Why?
|
| Skin Neoplasms | 2 | 2008 | 4654 | 0.050 |
Why?
|
| Gene Expression Regulation, Plant | 1 | 2000 | 92 | 0.040 |
Why?
|
| Arabinose | 1 | 1999 | 23 | 0.040 |
Why?
|
| Germ Cells | 1 | 2022 | 335 | 0.040 |
Why?
|
| Young Adult | 2 | 2018 | 21445 | 0.040 |
Why?
|
| Hydrogen Peroxide | 2 | 1990 | 217 | 0.040 |
Why?
|
| Cross-Linking Reagents | 1 | 2000 | 153 | 0.040 |
Why?
|
| Protein Sorting Signals | 1 | 1999 | 44 | 0.040 |
Why?
|
| Activating Transcription Factor 4 | 1 | 2019 | 73 | 0.040 |
Why?
|
| Plant Leaves | 1 | 1999 | 61 | 0.040 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2019 | 3821 | 0.040 |
Why?
|
| Cell Line | 1 | 2007 | 5114 | 0.040 |
Why?
|
| Abdomen | 1 | 2001 | 332 | 0.040 |
Why?
|
| Light | 1 | 2000 | 245 | 0.040 |
Why?
|
| Membrane Potential, Mitochondrial | 2 | 2010 | 133 | 0.040 |
Why?
|
| Enzyme Inhibitors | 2 | 2008 | 1879 | 0.040 |
Why?
|
| Hematopoiesis | 1 | 2022 | 560 | 0.040 |
Why?
|
| Uganda | 1 | 2018 | 74 | 0.040 |
Why?
|
| Open Reading Frames | 1 | 1999 | 250 | 0.040 |
Why?
|
| Molecular Weight | 1 | 1999 | 629 | 0.040 |
Why?
|
| Luciferases | 1 | 2000 | 445 | 0.040 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2000 | 611 | 0.040 |
Why?
|
| Temperature | 1 | 2000 | 506 | 0.040 |
Why?
|
| Triglycerides | 1 | 2001 | 603 | 0.040 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2005 | 3639 | 0.040 |
Why?
|
| Molecular Chaperones | 1 | 1999 | 264 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 7 | 1 | 2019 | 234 | 0.040 |
Why?
|
| Protein Precursors | 1 | 1999 | 240 | 0.040 |
Why?
|
| Species Specificity | 1 | 1999 | 777 | 0.040 |
Why?
|
| Caspase 3 | 2 | 2010 | 471 | 0.040 |
Why?
|
| Biological Transport | 1 | 1999 | 597 | 0.040 |
Why?
|
| Organ Specificity | 1 | 1999 | 699 | 0.040 |
Why?
|
| Gene Expression Profiling | 1 | 2010 | 5159 | 0.040 |
Why?
|
| DNA Replication | 1 | 2002 | 744 | 0.040 |
Why?
|
| Chromosome Banding | 1 | 2017 | 256 | 0.040 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2022 | 755 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 3 | 2005 | 6942 | 0.040 |
Why?
|
| Calcium-Binding Proteins | 1 | 1999 | 545 | 0.040 |
Why?
|
| Transcription, Genetic | 2 | 2007 | 3154 | 0.040 |
Why?
|
| Disease-Free Survival | 1 | 2008 | 10001 | 0.040 |
Why?
|
| Case-Control Studies | 2 | 2021 | 6100 | 0.040 |
Why?
|
| Gene Rearrangement | 1 | 2020 | 783 | 0.040 |
Why?
|
| Blood Glucose | 1 | 2001 | 1244 | 0.040 |
Why?
|
| Nerve Tissue Proteins | 1 | 2004 | 1491 | 0.040 |
Why?
|
| Neoplasm Proteins | 1 | 2008 | 3230 | 0.040 |
Why?
|
| Viral Load | 1 | 2018 | 493 | 0.030 |
Why?
|
| Genes, Transgenic, Suicide | 1 | 2016 | 69 | 0.030 |
Why?
|
| Gene Expression Regulation | 1 | 2007 | 4053 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2021 | 1945 | 0.030 |
Why?
|
| Retrospective Studies | 2 | 2019 | 37905 | 0.030 |
Why?
|
| Protein Biosynthesis | 1 | 2000 | 889 | 0.030 |
Why?
|
| Antigens, CD20 | 1 | 2016 | 206 | 0.030 |
Why?
|
| Transplant Recipients | 1 | 2018 | 324 | 0.030 |
Why?
|
| Retroviridae | 1 | 2016 | 332 | 0.030 |
Why?
|
| Complement System Proteins | 1 | 2016 | 139 | 0.030 |
Why?
|
| Fatal Outcome | 1 | 2017 | 829 | 0.030 |
Why?
|
| Disease Models, Animal | 2 | 2019 | 7222 | 0.030 |
Why?
|
| DNA-Binding Proteins | 2 | 1999 | 4821 | 0.030 |
Why?
|
| Virus Replication | 1 | 2018 | 709 | 0.030 |
Why?
|
| Repressor Proteins | 1 | 2022 | 1664 | 0.030 |
Why?
|
| Chromosome Deletion | 1 | 2019 | 1005 | 0.030 |
Why?
|
| RNA, Messenger | 2 | 2007 | 6150 | 0.030 |
Why?
|
| Radiotherapy | 1 | 2021 | 1824 | 0.030 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2016 | 675 | 0.030 |
Why?
|
| Phosphoproteins | 1 | 1999 | 1152 | 0.030 |
Why?
|
| Antineoplastic Agents | 2 | 2007 | 14289 | 0.030 |
Why?
|
| Follow-Up Studies | 2 | 2019 | 14889 | 0.030 |
Why?
|
| Calcium | 1 | 2000 | 1537 | 0.030 |
Why?
|
| Remission Induction | 1 | 2019 | 3569 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 1 | 2000 | 3101 | 0.030 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2005 | 3552 | 0.030 |
Why?
|
| Ubiquinone | 1 | 1992 | 37 | 0.030 |
Why?
|
| Kidney | 1 | 2001 | 2146 | 0.030 |
Why?
|
| Immunosuppressive Agents | 1 | 2018 | 1375 | 0.030 |
Why?
|
| Microsomes, Liver | 1 | 1992 | 115 | 0.030 |
Why?
|
| Glycerophosphates | 1 | 1991 | 4 | 0.030 |
Why?
|
| Spectrophotometry, Ultraviolet | 1 | 1991 | 71 | 0.030 |
Why?
|
| Cell Fractionation | 1 | 1991 | 68 | 0.030 |
Why?
|
| Mitochondria, Liver | 1 | 1991 | 49 | 0.030 |
Why?
|
| Citric Acid Cycle | 1 | 1991 | 86 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2010 | 2054 | 0.020 |
Why?
|
| Rituximab | 1 | 2016 | 1528 | 0.020 |
Why?
|
| Genetic Vectors | 1 | 2016 | 1694 | 0.020 |
Why?
|
| Basal Metabolism | 1 | 1990 | 88 | 0.020 |
Why?
|
| Mannose-Binding Lectins | 1 | 2010 | 29 | 0.020 |
Why?
|
| Colony-Forming Units Assay | 1 | 2010 | 249 | 0.020 |
Why?
|
| STAT Transcription Factors | 1 | 2010 | 79 | 0.020 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2016 | 1242 | 0.020 |
Why?
|
| Biopsy | 1 | 2017 | 3443 | 0.020 |
Why?
|
| Lectins, C-Type | 1 | 2010 | 162 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2021 | 5687 | 0.020 |
Why?
|
| Mutant Proteins | 1 | 2010 | 234 | 0.020 |
Why?
|
| Transplantation Conditioning | 1 | 2017 | 2238 | 0.020 |
Why?
|
| Adult | 4 | 2021 | 77950 | 0.020 |
Why?
|
| Transcription Factors | 1 | 2022 | 5270 | 0.020 |
Why?
|
| Adaptation, Physiological | 1 | 1990 | 360 | 0.020 |
Why?
|
| Receptors, Erythropoietin | 1 | 2008 | 70 | 0.020 |
Why?
|
| Caspase Inhibitors | 1 | 2008 | 95 | 0.020 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2010 | 324 | 0.020 |
Why?
|
| Lymph Nodes | 1 | 2019 | 2967 | 0.020 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2010 | 566 | 0.020 |
Why?
|
| Fusion Regulatory Protein 1, Heavy Chain | 1 | 2007 | 5 | 0.020 |
Why?
|
| Autophagy-Related Protein 5 | 1 | 2007 | 46 | 0.020 |
Why?
|
| Autophagy-Related Protein 7 | 1 | 2007 | 33 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2004 | 8873 | 0.020 |
Why?
|
| Chloroquine | 1 | 2007 | 53 | 0.020 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2008 | 367 | 0.020 |
Why?
|
| Beclin-1 | 1 | 2007 | 85 | 0.020 |
Why?
|
| Inhibitor of Apoptosis Proteins | 1 | 2008 | 202 | 0.020 |
Why?
|
| Binding Sites | 1 | 1991 | 2171 | 0.020 |
Why?
|
| Cytokines | 1 | 2016 | 2809 | 0.020 |
Why?
|
| DNA Probes | 1 | 2007 | 217 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2008 | 591 | 0.020 |
Why?
|
| Thermodynamics | 1 | 2006 | 196 | 0.020 |
Why?
|
| India | 1 | 2006 | 301 | 0.020 |
Why?
|
| Kinetics | 2 | 2004 | 2049 | 0.020 |
Why?
|
| Anaphase-Promoting Complex-Cyclosome | 1 | 2005 | 19 | 0.020 |
Why?
|
| Protein Transport | 1 | 2008 | 734 | 0.020 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2018 | 15862 | 0.020 |
Why?
|
| Ubiquitin-Protein Ligase Complexes | 1 | 2005 | 32 | 0.020 |
Why?
|
| Clone Cells | 1 | 2007 | 555 | 0.020 |
Why?
|
| Schizosaccharomyces pombe Proteins | 1 | 2005 | 84 | 0.020 |
Why?
|
| Cell Membrane Permeability | 1 | 2005 | 122 | 0.020 |
Why?
|
| Inactivation, Metabolic | 1 | 2005 | 37 | 0.020 |
Why?
|
| Drug Resistance, Fungal | 1 | 2005 | 92 | 0.020 |
Why?
|
| 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | 1 | 2005 | 96 | 0.020 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 2005 | 226 | 0.020 |
Why?
|
| Antigens, CD | 1 | 2010 | 1385 | 0.020 |
Why?
|
| Models, Biological | 2 | 1992 | 3254 | 0.020 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2007 | 413 | 0.020 |
Why?
|
| Myelodysplastic Syndromes | 1 | 2017 | 2979 | 0.020 |
Why?
|
| Dithiothreitol | 1 | 2004 | 21 | 0.020 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 1992 | 849 | 0.020 |
Why?
|
| rho GTP-Binding Proteins | 1 | 2005 | 177 | 0.020 |
Why?
|
| Glutathione Peroxidase | 1 | 2004 | 61 | 0.010 |
Why?
|
| Enzyme Induction | 1 | 2004 | 249 | 0.010 |
Why?
|
| Gene Frequency | 1 | 2007 | 1163 | 0.010 |
Why?
|
| Carcinogens | 1 | 2005 | 384 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2010 | 2508 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2018 | 12873 | 0.010 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2008 | 1033 | 0.010 |
Why?
|
| Sirolimus | 1 | 2007 | 814 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 2018 | 5542 | 0.010 |
Why?
|
| Down-Regulation | 1 | 2008 | 2074 | 0.010 |
Why?
|
| Piperidines | 1 | 2008 | 1035 | 0.010 |
Why?
|
| Cell Nucleus | 1 | 2008 | 1620 | 0.010 |
Why?
|
| Glutathione Transferase | 1 | 2004 | 359 | 0.010 |
Why?
|
| Cell Cycle | 1 | 2008 | 2084 | 0.010 |
Why?
|
| Peptides | 1 | 2007 | 1479 | 0.010 |
Why?
|
| Glutathione | 1 | 2004 | 368 | 0.010 |
Why?
|
| RNA, Small Interfering | 1 | 2007 | 2216 | 0.010 |
Why?
|
| Risk Factors | 1 | 2018 | 17523 | 0.010 |
Why?
|
| Calnexin | 1 | 1999 | 11 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2008 | 4938 | 0.010 |
Why?
|
| Microsomes | 1 | 1999 | 61 | 0.010 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2017 | 6550 | 0.010 |
Why?
|
| Middle Aged | 2 | 2021 | 86204 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2004 | 2063 | 0.010 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2007 | 1823 | 0.010 |
Why?
|
| Skin | 1 | 2005 | 1259 | 0.010 |
Why?
|
| Protein Binding | 1 | 2005 | 3438 | 0.010 |
Why?
|
| Transfection | 1 | 2004 | 2944 | 0.010 |
Why?
|
| Genotype | 1 | 2006 | 4109 | 0.010 |
Why?
|
| Biomarkers | 1 | 2010 | 5047 | 0.010 |
Why?
|
| Rabbits | 1 | 1999 | 957 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2004 | 2927 | 0.010 |
Why?
|
| Endoplasmic Reticulum | 1 | 1999 | 308 | 0.010 |
Why?
|
| Dogs | 1 | 1999 | 1155 | 0.010 |
Why?
|
| Electrophoresis, Agar Gel | 1 | 1996 | 82 | 0.010 |
Why?
|
| In Vitro Techniques | 1 | 1999 | 1618 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2007 | 2819 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 1996 | 329 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 1996 | 600 | 0.010 |
Why?
|
| Protein Processing, Post-Translational | 1 | 1999 | 803 | 0.010 |
Why?
|
| Time Factors | 1 | 2008 | 12926 | 0.010 |
Why?
|
| Antibodies | 1 | 1996 | 838 | 0.010 |
Why?
|
| Hydroxymethylglutaryl CoA Reductases | 1 | 1992 | 44 | 0.010 |
Why?
|
| Feedback | 1 | 1992 | 198 | 0.010 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2004 | 2027 | 0.010 |
Why?
|
| Gene Expression | 1 | 1999 | 3570 | 0.010 |
Why?
|
| Reference Values | 1 | 1992 | 1099 | 0.010 |
Why?
|
| Cholesterol | 1 | 1992 | 658 | 0.010 |
Why?
|
| DNA | 1 | 1996 | 2693 | 0.000 |
Why?
|
| Liver Neoplasms | 1 | 2004 | 4557 | 0.000 |
Why?
|
| Aged | 1 | 2008 | 70117 | 0.000 |
Why?
|